annual EBIT:
-$265.50M-$81.15M(-44.02%)Summary
- As of today (September 14, 2025), RYTM annual earnings before interest & taxes is -$265.50 million, with the most recent change of -$81.15 million (-44.02%) on December 31, 2024.
- During the last 3 years, RYTM annual EBIT has fallen by -$95.44 million (-56.12%).
- RYTM annual EBIT is now -3989.07% below its all-time high of -$6.49 million, reached on December 1, 2014.
Performance
RYTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$45.30M+$1.71M(+3.63%)Summary
- As of today (September 14, 2025), RYTM quarterly earnings before interest & taxes is -$45.30 million, with the most recent change of +$1.71 million (+3.63%) on June 30, 2025.
- Over the past year, RYTM quarterly EBIT has dropped by -$4.82 million (-11.90%).
- RYTM quarterly EBIT is now -14654.40% below its all-time high of -$307.00 thousand, reached on September 1, 2014.
Performance
RYTM quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$177.44M-$4.82M(-2.79%)Summary
- As of today (September 14, 2025), RYTM TTM earnings before interest & taxes is -$177.44 million, with the most recent change of -$4.82 million (-2.79%) on June 30, 2025.
- Over the past year, RYTM TTM EBIT has increased by +$88.14 million (+33.19%).
- RYTM TTM EBIT is now -4470.84% below its all-time high of -$3.88 million, reached on September 1, 2015.
Performance
RYTM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RYTM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.0% | -11.9% | +33.2% |
| 3 y3 years | -56.1% | -0.4% | +8.1% |
| 5 y5 years | -81.8% | -41.9% | -28.1% |
RYTM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.1% | at low | -15.3% | +67.6% | -2.8% | +34.7% |
| 5 y | 5-year | -94.4% | at low | -41.9% | +67.6% | -30.8% | +34.7% |
| alltime | all time | -3989.1% | at low | <-9999.0% | +67.6% | -4470.8% | +34.7% |
RYTM EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$45.30M(-3.6%) | -$177.44M(+2.8%) |
| Mar 2025 | - | -$47.00M(+13.9%) | -$172.62M(-35.0%) |
| Dec 2024 | -$265.50M(+44.0%) | -$41.26M(-6.0%) | -$265.50M(-0.0%) |
| Sep 2024 | - | -$43.88M(+8.4%) | -$265.51M(-0.0%) |
| Jun 2024 | - | -$40.48M(-71.1%) | -$265.58M(-2.3%) |
| Mar 2024 | - | -$139.89M(+239.0%) | -$271.71M(+47.4%) |
| Dec 2023 | -$184.36M(+2.9%) | -$41.27M(-6.1%) | -$184.35M(-0.5%) |
| Sep 2023 | - | -$43.95M(-5.7%) | -$185.19M(+2.6%) |
| Jun 2023 | - | -$46.60M(-11.3%) | -$180.51M(+0.8%) |
| Mar 2023 | - | -$52.53M(+24.8%) | -$179.00M(-0.1%) |
| Dec 2022 | -$179.16M(+5.3%) | -$42.10M(+7.2%) | -$179.16M(-4.7%) |
| Sep 2022 | - | -$39.27M(-12.9%) | -$188.04M(-2.6%) |
| Jun 2022 | - | -$45.10M(-14.4%) | -$193.02M(+2.5%) |
| Mar 2022 | - | -$52.69M(+3.3%) | -$188.35M(+10.8%) |
| Dec 2021 | -$170.06M(+24.5%) | -$50.99M(+15.3%) | -$170.06M(+10.3%) |
| Sep 2021 | - | -$44.24M(+9.4%) | -$154.14M(+6.9%) |
| Jun 2021 | - | -$40.43M(+17.5%) | -$144.19M(+6.3%) |
| Mar 2021 | - | -$34.40M(-1.9%) | -$135.67M(-0.7%) |
| Dec 2020 | -$136.57M(-6.5%) | -$35.07M(+2.3%) | -$136.57M(+0.6%) |
| Sep 2020 | - | -$34.28M(+7.4%) | -$135.73M(-2.0%) |
| Jun 2020 | - | -$31.92M(-9.6%) | -$138.55M(-8.1%) |
| Mar 2020 | - | -$35.30M(+3.1%) | -$150.78M(+3.3%) |
| Dec 2019 | -$146.00M | -$34.22M(-7.8%) | -$146.00M(+5.1%) |
| Sep 2019 | - | -$37.11M(-16.0%) | -$138.93M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$44.15M(+44.7%) | -$121.06M(+31.7%) |
| Mar 2019 | - | -$30.52M(+12.4%) | -$91.94M(+17.2%) |
| Dec 2018 | -$78.42M(+141.9%) | -$27.15M(+41.1%) | -$78.42M(+26.0%) |
| Sep 2018 | - | -$19.24M(+28.1%) | -$62.25M(+21.4%) |
| Jun 2018 | - | -$15.02M(-11.6%) | -$51.29M(+19.2%) |
| Mar 2018 | - | -$17.00M(+54.8%) | -$43.02M(+32.7%) |
| Dec 2017 | -$32.41M(+25.1%) | -$10.98M(+32.5%) | -$32.41M(+51.3%) |
| Sep 2017 | - | -$8.29M(+22.7%) | -$21.43M(+63.0%) |
| Jun 2017 | - | -$6.75M(+5.7%) | -$13.14M(+8.4%) |
| Mar 2017 | - | -$6.39M(+11.3%) | -$12.13M(-39.0%) |
| Dec 2016 | -$25.91M(+145.0%) | - | - |
| Jun 2016 | - | -$5.74M(+6.4%) | -$19.89M(+40.5%) |
| Mar 2016 | - | -$5.39M(-4.5%) | -$14.15M(+61.5%) |
| Dec 2015 | -$10.57M(+62.8%) | - | - |
| Dec 2015 | - | -$5.64M(+80.9%) | -$8.76M(+125.7%) |
| Sep 2015 | - | -$3.12M(+309.4%) | -$3.88M(-51.7%) |
| Dec 2014 | -$6.49M(-69.7%) | -$762.00K(+148.2%) | -$8.04M(+10.5%) |
| Sep 2014 | - | -$307.00K(-91.1%) | -$7.28M(+4.4%) |
| Jun 2014 | - | -$3.44M(-2.8%) | -$6.97M(-29.5%) |
| Mar 2014 | - | -$3.54M(-44.3%) | -$9.89M(-8.7%) |
| Dec 2013 | -$21.45M(+18.2%) | - | - |
| Jun 2013 | - | -$6.35M(+41.7%) | -$10.83M(+141.7%) |
| Mar 2013 | - | -$4.48M | -$4.48M |
| Dec 2012 | -$18.14M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of RYTM is -$265.50M
What is the all time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$6.49M
What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, RYTM annual earnings before interest & taxes has changed by -$81.15M (-44.02%)
What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of RYTM is -$45.30M
What is the all time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is -$307.00K
What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, RYTM quarterly earnings before interest & taxes has changed by -$4.82M (-11.90%)
What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of RYTM is -$177.44M
What is the all time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$3.88M
What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, RYTM TTM earnings before interest & taxes has changed by +$88.14M (+33.19%)